Updated Aug 05, 2020

MAMAOPE: PNEUMONIA DIAGNOSTIC DEVICE FOR LOW RESOURCE CLINICAL SETTINGS

http://mamaope.com/

Mamaope Medicals

MamaOpe is a non-invasive device designed to accurately detect pneumonia in low resource settings using patient vitals.

It determines and interprets Respiratory Rate and lung sounds for the diagnosis of respiratory disease using acoustic sensors placed over strategic lung fields. The device is strapped around the child’s chest and measures breathing rate and lung sounds, which are analyzed using machine learning to diagnose pneumonia. Patient data can be uploaded on the cloud for remote consultation or telemedic...
SEE ALL
It determines and interprets Respiratory Rate and lung sounds for the diagnosis of respiratory disease using acoustic sensors placed over strategic lung fields. The device is strapped around the child’s chest and measures breathing rate and lung sounds, which are analyzed using machine learning to diagnose pneumonia. Patient data can be uploaded on the cloud for remote consultation or telemedicine application.
SEE LESS
Testing
  

Stage 4: Transition to Scale

MamaOpe prototype’s accuracy in measuring respiratory rate and lung sounds was evaluated at the Mbarara University of Science & Technology (MUST), SIM4Life Laboratory and it demonstrated an accuracy (87.9% ±0.98; n = 1,053).

Focus Areas:

Medical Devices, Infectious & Vector Diseases, Maternal Newborn and Child Health and 1 MoreSEE ALL

Medical Devices, Infectious & Vector Diseases, Maternal Newborn and Child Health and Health SystemsSEE LESS

Implemented In:

Uganda

UgandaSEE LESS

1
Country Implemented In
5
Employees
$111,000
Funds Raised to Date
Verified Funding
?

Problem

Early diagnosis of pneumonia is vital for improved treatment outcomes; however, most health workers fail to correctly count the RR and decipher lung sounds resulting in delayed pneumonia diagnosis, delayed treatment and complications. There are 120 million episodes of pneumonia per year globally in children under 5, over 10% of these progress to severe episodes (WHO, 2016 factsheet). Pneumonia is the world’s leading cause of death among children under 5 years of age, accounting for 16% deaths.

}

Solution

It determines and interprets Respiratory Rate and lung sounds for the diagnosis of respiratory disease using acoustic sensors placed over strategic lung fields. The device is strapped around the child’s chest and measures breathing rate and lung sounds, which are analyzed using machine learning to diagnose pneumonia. Patient data can be uploaded on the cloud for remote consultation or telemedicine application.

Target Beneficiaries

We project to launch MamaOpe in Uganda by 2023, scale into East Africa by 2025 and across Africa by 2030. Each of these markets will have private, public and NGO customer segments that will be targeted in that order. The early adopters for the device are anticipated to be from the private health sector. This includes over 27 general hospitals and 3,318 clinics in Uganda. Public sector and NGOs require strong evidence and policy advocacy to adopt innovations.

Mission and Vision

MamaOpe Medicals is a social venture that develops innovative solutions to improve access to quality health care for people in low resource settings, giving them a fair chance at life. Our mission is to improve the diagnosis and management of acute respiratory infections using digital tools.
Funding Goal500,000

Milestone

May 2018
Funds RaisedVERIFIED
$25,000
ORGANIZATIONVillgroVillgro 
as part of
 Villgro KenyaVillgro Kenya
Date Unknown
New Country Implemented In
Uganda
COVID-19 Innovation Hub IS POWERED BY GLOBAL INNOVATION EXCHANGE, A TECH PLATFORM FOR GLOBAL DEVELOPMENT INNOVATIONS.

Privacy Policy and Terms and Conditions